ACON
ACON
Positions held
Your positionsACON isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-08 · Aclarion Broadens CLARITY Trial Enrollment Criteria to Accelerate Enrollment
2026-09-29 · Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
2026-08-20 · Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
2026-08-06 · Aclarion, Inc. (ACON) Reports Q2 Loss, Lags Revenue Estimates
2026-07-29 · Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
Price (daily)
Full chart · RSI · MACD · patterns